HBM Partners was founded in 2001 with the goal to invest in private and public emerging biopharma and other healthcare-related companies.
HBM Partners has a team of experienced professionals to source, analyse and engage in investments in biopharma, medical devices and diagnostics industries. HBM Partners has a track-record of over 100 investments that resulted so far in significant value creation by more than 50 trade sales and IPOs since inception.
HBM Partners is regulated by FINMA and advises SWX listed HBM Healthcare Investments and further specialised public and private equity investment products.
"HBM Partners supports outstanding entrepreneurs. Together, we champion innovative ventures and build exceptional companies"
Dr. Andreas Wicki, CEO